Should more patients be offered repair for mitral valve endocarditis? a single-centre 15-year experience.


Journal

Journal of cardiothoracic surgery
ISSN: 1749-8090
Titre abrégé: J Cardiothorac Surg
Pays: England
ID NLM: 101265113

Informations de publication

Date de publication:
30 Sep 2022
Historique:
received: 16 05 2022
accepted: 18 09 2022
entrez: 30 9 2022
pubmed: 1 10 2022
medline: 5 10 2022
Statut: epublish

Résumé

To describe the long-term outcomes of mitral valve repair (MVr) versus mitral valve replacement (MVR) in patients with native valve infective endocarditis (IE) at a centre with high-repair rates. We conducted a retrospective single-centre cohort study. From 2005 to 2021, 183 patients with active or healed native valve IE were included. The primary outcome was long-term mortality. Patient status was last confirmed 31 March 2021. Secondary outcomes were post-operative MR, MV reoperation, length of post-operative intensive care stay and total hospital stay. 85 patients (46.4%) underwent MVr and 98 (53.6%) underwent MVR. Follow-up was 98.9% complete. Mean follow-up time was 5.3 years with 17% of patients reaching a follow-up time of over 10 years. There were 47 deaths (25.7%) within the follow-up period. MVR patients were more likely to have higher logistic EuroSCORE, active IE and were less likely to have elective surgery. In multivariate Cox proportional hazards analysis, there was no significant difference in long-term mortality between MVr and MVR groups (hazard ratio 1.09, 95% confidence interval [0.59-2.00]). In Kaplan-Meier analysis, MVR patients had a higher all-cause mortality although there was no significant difference at the endpoint. Propensity score matching analysis showed a significantly higher mortality in the replacement group instead (p = 0.002), Subgroup analysis revealed there remained no significant difference in mortality even in patients with active IE (P-interaction = 0.859) or non-elective surgery (P-interaction = 0.122). MV reoperation (odds ratio 1.00 [0.24-4.12]), post-operative intensive care stay (p = 0.9650) and total hospital stay (p = 0.9144) were comparable. Our data demonstrates repair was at least non-inferior to replacement in IE, supporting more aggressive use of repair. There is no reason the general principle of why repair is superior to replacement should not hold in IE, with enough operator expertise. Other experienced units should be encouraged to increase repair rates as feasible in line with current guidelines.

Identifiants

pubmed: 36180915
doi: 10.1186/s13019-022-01997-2
pii: 10.1186/s13019-022-01997-2
pmc: PMC9523968
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

243

Informations de copyright

© 2022. The Author(s).

Références

Gen Thorac Cardiovasc Surg. 2014 Aug;62(8):488-98
pubmed: 24522750
J Thorac Cardiovasc Surg. 2018 Oct;156(4):1473-1483.e2
pubmed: 29843917
Ann Cardiothorac Surg. 2019 Nov;8(6):630-644
pubmed: 31832353
Patient Prefer Adherence. 2011 Feb 17;5:91-9
pubmed: 21448466
Eur J Cardiothorac Surg. 2007 Apr;31(4):592-9
pubmed: 17270457
J Card Surg. 2018 Jul;33(7):364-371
pubmed: 29926515
Ann Thorac Surg. 2009 May;87(5):1431-7; discussion 1437-9
pubmed: 19379881
Eur J Cardiothorac Surg. 2008 Mar;33(3):391-401
pubmed: 18249001
Ann Thorac Surg. 1990 May;49(5):706-11; discussion 712-3
pubmed: 2339926
J Card Surg. 2019 Jul;34(7):583-590
pubmed: 31212382
Heart. 2013 Oct;99(20):1494-501
pubmed: 23335498
Ann Thorac Surg. 2009 Dec;88(6):1828-37
pubmed: 19932244
Ann Cardiothorac Surg. 2015 May;4(3):230-7
pubmed: 26309824
J Heart Valve Dis. 2000 May;9(3):335-40
pubmed: 10888087
J Heart Valve Dis. 2001 Jan;10(1):72-7
pubmed: 11206771
Circulation. 1995 Feb 15;91(4):1022-8
pubmed: 7850937
Asian Cardiovasc Thorac Ann. 2014 Oct;22(8):919-26
pubmed: 24585289
J Heart Valve Dis. 2004 Sep;13(5):754-9
pubmed: 15473475
Clin Infect Dis. 2000 Apr;30(4):633-8
pubmed: 10770721
Ann Thorac Surg. 1997 Jun;63(6):1718-24
pubmed: 9205173
Ann Thorac Surg. 2005 Dec;80(6):2199-204
pubmed: 16305871
Ann Thorac Surg. 2007 Feb;83(2):564-70
pubmed: 17257988
J Thorac Cardiovasc Surg. 2005 Sep;130(3):765-71
pubmed: 16153926
Eur J Cardiothorac Surg. 2011 Oct;40(4):834-9
pubmed: 21459600
J Am Coll Cardiol. 2004 Feb 4;43(3):386-92
pubmed: 15013119
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109

Auteurs

Clarissa Ng Yin Ling (C)

Department of Cardiothoracic Surgery, King's College Hospital, London, UK. clarissa.ngyinling@nhs.net.
Department of Surgery and Cancer, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK. clarissa.ngyinling@nhs.net.

David Bleetman (D)

Department of Cardiothoracic Surgery, King's College Hospital, London, UK.

Soumik Pal (S)

Department of Cardiothoracic Surgery, King's College Hospital, London, UK.

Hing Chi Kristie Leung (HCK)

University College London, London, UK.

Habib Khan (H)

Department of Cardiothoracic Surgery, King's College Hospital, London, UK.

Donald Whitaker (D)

Department of Cardiothoracic Surgery, King's College Hospital, London, UK.

Olaf Wendler (O)

Department of Cardiothoracic Surgery, King's College Hospital, London, UK.

Ranjit Deshpande (R)

Department of Cardiothoracic Surgery, King's College Hospital, London, UK.

Max Baghai (M)

Department of Cardiothoracic Surgery, King's College Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH